Gvs Logo

Gvs

ISIN

IT0005411209

Ticker

GVS

Sector

Health Care

Sub-Industry

Health Care Supplies

Country

Italy

Year Founded

1979

About Gvs

Company Description

GVS Group is one of the world’s leading manufacturers of filter solutions for applications in the Healthcare & Life Sciences, Energy & Mobility, and Health & Safety sectors.

In over 40 years of history, GVS has evolved from a supplier of components for the healthcare sector to a global Group that produces highly technological diversified filtration solutions.
The Group has always paid great attention to research, development and innovation of its products and processes and has shown a strong trend towards development in global markets since its foundation.

In addition to the Corporate headquarters in Bologna, GVS currently has 15 plants in Italy, United Kingdom, Brazil, United States, China, Malaysia, Mexico, Romania e Puerto Rico, and 18 commercial offices located all over the world.

GVS has always adopted a “glocal” approach: it operates locally in contact with its customers, but relies on the strength of a global network.

Served Area

Worldwide

Headquarters

Via Roma 50
40069, Zola Predosa
Italy

Financial statements

Download as Excel
Line item in (eur) 01.01.2021 01.01.2022 01.01.2023
Other Noncurrent Receivables N/A 0.00 1,695,000.00
Noncurrent Derivative Financial Assets 0.00 123,000.00 6,648,000.00
Cash and cash equivalents 125,068,000.00 136,893,000.00 135,169,000.00
Noncurrent Financial Liabilities At Amortised Cost 69,728,000.00 180,164,000.00 10,989,000.00
Noncurrent Derivative Financial Liabilities 107,000.00 0.00 N/A
Current Contract Liabilities 4,894,000.00 3,417,000.00 7,224,000.00
Current Financial Liabilities At Amortised Cost 19,673,000.00 41,706,000.00 438,238,000.00
Line item in (eur) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue From Contracts With Customers 363,296,000.00 338,126,000.00 387,591,000.00
Services Expense 36,216,000.00 36,662,000.00 54,573,000.00
Profit (loss) 78,083,000.00 67,604,000.00 24,120,000.00
Line item in (eur) 01.01.2021 01.01.2022 01.01.2023
Profit (loss) 78,083,000.00 67,604,000.00 24,120,000.00
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes 69,569,000.00 7,954,000.00 -1,527,000.00
Cash and cash equivalents 125,068,000.00 136,893,000.00 135,169,000.00

Please note that some sums might not add up.

Filings & Publications

  • Consolidated Report 2022 - Q4 English 🇬🇧 Published: 30.05.2023
  • Consolidated Report 2021 - Q4 Italian 🇮🇹 Published: 30.05.2023

Capital Markets Information

ISIN

IT0005411209

LEI

81560013EACB40B52D17

Listed Stock Exchange

Borsa Italiana

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.